VANCOUVER, British Columbia, Oct. 06, 2020 (GLOBE NEWSWIRE) — Derm-Biome Pharmaceuticals, Inc, a private Vancouver based biopharmaceutical company focused on skin health and healthy ageing, is pleased to announce that… Read More
VICTORIA, British Columbia–(BUSINESS WIRE)–Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today announced that the Company’s Compensation… Read More
Vancouver, Canada – Virogin Biotech is pleased to announce the completion of its Series C round of financing for a total of $62 million USD on September 20, 2020. Virogin… Read More
Industry innovator developing clinically proven, pharmaceutical grade health products adds experienced pharmaceutical executive to its team VANCOUVER, B.C. September 28, 2020/ ImmunoFlex™, a life sciences company developing clinically validated, pharmaceutical… Read More
Voclosporin ophthalmic solution (VOS) results on track to be reported in the fourth quarter of 2020 Study builds on positive head-to-head data with approved treatment reported in prior Phase 2a… Read More
